Vaccine-Med @Vaccine-Med: "Dear Investors, Here is your monthly..."

Smart Portfolio

Dear Investors, Here is your monthly update for October 2025 ✨ Global equities extended their rally in October, hitting record highs as tech strength, easing U.S.-China tensions, and expectations of lower interest rates supported investor optimism. Nvidia reached a record $5 trillion valuation, fueling excitement around AI, while major partnerships across the sector—from AMD to Google and Microsoft—kept innovation and earnings in focus. The Fed cut rates by 0.25% and the ECB held steady, while gold and copper hit new highs and oil weakened. Bitcoin’s rally faded late in the month amid profit-taking. 💭 Find out more about what happened in October with eToro's Smart Portfolios Monthly summary here: etoro.turtl.co/story/etoros-investment-office-performance-report-oct25 Performance Stats: @Vaccine-Med-> October: 0.93% , QTD: 0.93% YTD: 0.17% Benchmark (SGH - S&P Global 1200 Health Care Sector GICS Level 1 Index) -> October: 2.97% , QTD: 2.97% YTD: 5.22% Best Performer: $PSNL (Personalis Inc) 47.85% Worst Performer: $ARCT (Arcturus Therapeutics Holdings Inc) -45.90% Portfolio Indicated Dividend Yield: 1.08% Some of the assets inside the @Vaccine-Med Smart Portfolio are: $BAVA.CO (Bavarian Nordic A/S) , $NVAX (Novavax Inc) , $CVAC , $DVAX (Dynavax Technologies Corp) , $VLA.PA (Valneva SE) , $MRVI (Maravai LifeSciences Holdings Inc.) , $VIR (Vir Biotechnology Inc) , $EBS (Emergent BioSolutions Inc) , $VXRT (Vaxart Inc) ❓ Check out the portfolio fact sheet by clicking the following link: bullaware.com/factsheet/Vaccine-Med This Smart Portfolio is a long-term investment vehicle. Therefore, since market trends can change over time, you should set realistic goals and assess your investment performance over a prolonged period. Please remember past performance is not indicative of any future performance.